Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Isaacs

Showing results (261-270 of 575) with videos related to

Pageof 58
Sort By:
Scientific Reports|December 23, 2017
The expression of AURKA is androgen regulated in castration-resistant prostate cancerKati Kivinummi, Alfonso Urbanucci, Katri Leinonen, et al.
Cancer Research|May 8, 2007
Integration of somatic deletion analysis of prostate cancers and germline linkage analysis of prostate cancer families reveals two small consensus regions for prostate cancer genes at 8pBao-Li Chang, Wennuan Liu, Jishan Sun, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2015
The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other MalignanciesJennifer L Beebe-Dimmer, Matthew Hathcock, Cecilia Yee, et al.
Cancer Research|November 1, 1995
Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin functionC M Ewing, N Ru, R A Morton, et al.
Cancer Research|October 1, 1996
Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic lossJ T Dong, H Suzuki, S S Pin, et al.
The Prostate|June 22, 2010
Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic VariationSeong-Tae Kim, Yu Cheng, Fang-Chi Hsu, et al.
Urology|April 3, 2003
Familial aggregation of bothersome benign prostatic hyperplasia symptomsJay D Pearson, Hsien-Hsien Lei, Terri H Beaty, et al.
Advances in Enzyme Regulation|December 8, 2004
Sequence variants in the 3'-->5' deoxyribonuclease TREX2: identification in a genetic screen and effects on catalysis by the recombinant proteinsFred W Perrino, Anna Krol, Scott Harvey, et al.
The Prostate|March 26, 2008
Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammationKazutoshi Fujita, Charles M Ewing, Lori J Sokoll, et al.
European Urology|June 15, 2012
The role of genetic markers in the management of prostate cancerAtish D Choudhury, Rosalind Eeles, Stephen J Freedland, et al.
Pageof 58

Showing results (261-270 of 575) with videos related to

Sort By:
Pageof 58
Scientific Reports|December 23, 2017
The expression of AURKA is androgen regulated in castration-resistant prostate cancerKati Kivinummi, Alfonso Urbanucci, Katri Leinonen, et al.
Cancer Research|May 8, 2007
Integration of somatic deletion analysis of prostate cancers and germline linkage analysis of prostate cancer families reveals two small consensus regions for prostate cancer genes at 8pBao-Li Chang, Wennuan Liu, Jishan Sun, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2015
The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other MalignanciesJennifer L Beebe-Dimmer, Matthew Hathcock, Cecilia Yee, et al.
Cancer Research|November 1, 1995
Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin functionC M Ewing, N Ru, R A Morton, et al.
Cancer Research|October 1, 1996
Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic lossJ T Dong, H Suzuki, S S Pin, et al.
The Prostate|June 22, 2010
Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic VariationSeong-Tae Kim, Yu Cheng, Fang-Chi Hsu, et al.
Urology|April 3, 2003
Familial aggregation of bothersome benign prostatic hyperplasia symptomsJay D Pearson, Hsien-Hsien Lei, Terri H Beaty, et al.
Advances in Enzyme Regulation|December 8, 2004
Sequence variants in the 3'-->5' deoxyribonuclease TREX2: identification in a genetic screen and effects on catalysis by the recombinant proteinsFred W Perrino, Anna Krol, Scott Harvey, et al.
The Prostate|March 26, 2008
Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammationKazutoshi Fujita, Charles M Ewing, Lori J Sokoll, et al.
European Urology|June 15, 2012
The role of genetic markers in the management of prostate cancerAtish D Choudhury, Rosalind Eeles, Stephen J Freedland, et al.
Pageof 58